Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

ProteinLogic has developed ImmiPrint®, a novel diagnostic technology platform that detects non-obvious diagnostic patterns in soluble immune proteins in blood and other body fluids using machine…

ProteinLogic has developed ImmiPrint®, a novel diagnostic technology platform that detects non-obvious diagnostic patterns in soluble immune proteins in blood and other body fluids using machine…
Company: ProteinLogic — Cambridge, UK biomarker diagnostics spinout
Platform: ImmiPrint® — ML-driven soluble immune protein signature diagnostics
Lead program: Blood-based rule-out test for Active Tuberculosis (TB) with multi-site validation
Notable funders: Bill & Melinda Gates Foundation; EU Horizon 2020 grants
Diagnostics for infectious, autoimmune, and inflammatory diseases, with an initial focus on Active Tuberculosis.
2003
Biotechnology
1350000
Grant to develop TB diagnostic in collaboration with Stellenbosch University
Supported TB and early-stage cancer diagnosis projects (ADVANTAGE 666308 and other Horizon 2020 funding referenced)
“Received grant funding from philanthropic and European public programs (Bill & Melinda Gates Foundation; Horizon 2020)”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,500+
New This Week